ArticleAnnals of neurology2022

Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.

Nelly Joseph-Mathurin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.